Augmented Zika and Dengue Neutralizing Antibodies Are Associated With Guillain-Barré Syndrome.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 06 04 2018
accepted: 02 08 2018
pubmed: 17 8 2018
medline: 15 11 2019
entrez: 17 8 2018
Statut: ppublish

Résumé

The role of neutralizing antibodies in Zika-induced Guillain-Barré syndrome (GBS) has not yet been investigated. We conducted a case-control study using sera from the 2016 Zika epidemic in Colombia to determine the neutralizing antibody activity against Zika virus (ZIKV) and dengue virus serotype 2 (DENV2). We observed increased neutralizing antibody titers against DENV2 in ZIKV-infected individuals compared with uninfected controls and higher titers to both ZIKV and DENV2 in ZIKV-infected patients diagnosed with GBS compared with non-GBS ZIKV-infected controls. These data suggest that high neutralizing antibody titers to DENV and to ZIKV are associated with GBS during ZIKV infection.

Identifiants

pubmed: 30113672
pii: 5064749
doi: 10.1093/infdis/jiy466
pmc: PMC6284544
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

26-30

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI106695
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001876
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR001877
Pays : United States

Références

Sci Immunol. 2017 Aug 18;2(14):null
pubmed: 28821561
MMWR Morb Mortal Wkly Rep. 2016 Sep 02;65(34):910-4
pubmed: 27584942
Lancet. 1998 Aug 22;352(9128):635-41
pubmed: 9746040
Vaccine. 2011 Jan 10;29(3):599-612
pubmed: 20600491
J Autoimmun. 2017 Feb;77:123-138
pubmed: 28062188
J Crit Care. 2017 Feb;37:19-23
pubmed: 27610587
N Engl J Med. 2016 Oct 20;375(16):1513-1523
pubmed: 27705091
Cell. 2017 May 04;169(4):597-609.e11
pubmed: 28475892
JAMA Neurol. 2017 Oct 1;74(10):1190-1198
pubmed: 28806453
Cell Rep. 2016 Aug 9;16(6):1485-1491
pubmed: 27481466
Lancet. 2016 Apr 9;387(10027):1531-1539
pubmed: 26948433
N Engl J Med. 2016 Apr 21;374(16):1506-9
pubmed: 26959308
Autoimmun Rev. 2017 Apr;16(4):327-334
pubmed: 28216074
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8384-8389
pubmed: 28716913

Auteurs

Rebecca M Lynch (RM)

Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, District of Columbia.

Grace Mantus (G)

Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, District of Columbia.

Liliana Encinales (L)

Department of Medicine, Allied Research Society LLC, Baranquilla.

Nelly Pacheco (N)

Department of Medicine, Allied Research Society LLC, Baranquilla.

Guangzhao Li (G)

Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, District of Columbia.

Alexandra Porras (A)

Grupo de Medicina Comunitaria, Universidad El Bosque, Bogotá, Colombia.

Alejandro R Mendoza (AR)

Grupo de Medicina Comunitaria, Universidad El Bosque, Bogotá, Colombia.

Jin Peng (J)

Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, District of Columbia.

Monica Rengifo-Pardo (M)

Department of Dermatology, George Washington University, Washington, District of Columbia.

Magelda Montoya Cruz (MM)

Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley.

Eva Harris (E)

Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley.

Jeff M Bethony (JM)

Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, District of Columbia.

Gary L Simon (GL)

Department of Medicine, George Washington University, Washington, District of Columbia.

Aileen Y Chang (AY)

Department of Medicine, George Washington University, Washington, District of Columbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH